Cingulate Inc. to Present at the LD Micro Main Event XVI
21 Settembre 2023 - 7:30PM
Cingulate Inc. (NASDAQ:CING), a
biopharmaceutical company utilizing its proprietary Precision Timed
Release™ (PTR™) drug delivery platform technology to build and
advance a pipeline of next-generation pharmaceutical products,
announced today that Chairman & CEO, Shane J.
Schaffer, will be presenting a company overview at the
16th annual Main Event on Wednesday, October 4th at 02:30 PM PT at
the Luxe Sunset Boulevard Hotel.
"We know what this event means to our industry and how much
people enjoy attending. Thanks to the leaders at our parent
company, Freedom, who fully align with our vision, we continue to
provide a conference that is much more than meetings and
presentations – we're building the foundation for the coming
decades as the one event in small-cap that no one can afford to
miss. I am honored to host our close friends and allies for our
‘Sweet Sixteen’ installment of the Main Event," stated Chris
Lahiji, Founder of LD Micro.
Event: LD Micro Main Event
XVDate: Wednesday, October
4thTime: 02:30 PM PT
Register to watch the virtual
presentation here
Summary of LD Micro Main Event XVI
The 2023 LD Micro Main Event XVI will run
from October 3rd to the 5th at the Luxe
Sunset Boulevard Hotel in Los Angeles.
Presentations will run from 8:00 AM PT - 5:00 PM PT on the 3rd
and 4th, with a half day on Thursday the 5th.
This three-day event will feature around 200 companies,
presenting in half-hour increments, and attending private meetings
with investors.
About Cingulate Inc.
Cingulate is a biopharmaceutical company utilizing its
proprietary PTR drug delivery platform technology to build and
advance a pipeline of next-generation pharmaceutical products,
designed to improve the lives of patients suffering from frequently
diagnosed conditions characterized by burdensome daily dosing
regimens and suboptimal treatment outcomes. With an initial focus
on the treatment of ADHD, Cingulate is identifying and evaluating
additional therapeutic areas where PTR technology may be employed
to develop future product candidates, including to treat anxiety
disorders. Cingulate is headquartered in Kansas City. For more
information visit Cingulate.com
About LD Micro
LD Micro, a wholly owned subsidiary of Freedom US Markets, was
founded in 2006 with the sole purpose of being an independent
resource in the micro-cap space. Through the LD Micro Index and
annual investor conferences, LD has served as an invaluable asset
to all those interested in discovering the next generation of great
companies. For more information on LD Micro,
visit www.ldmicro.com
To present or register, please
contact registration@ldmicro.com
To learn more about Freedom US Markets,
visit www.freedomusmkts.com
Investor Relations:
Thomas DaltonVice President, Investor &
Public Relations,
Cingulatetdalton@cingulate.com 913-942-2301
Matt KrepsDarrow
Associatesmkreps@darrowir.com 214-597-8200
Media Relations:
Melyssa WeibleElixir Health Public
Relations mweible@elixirhealthpr.com201-723-5805
Grafico Azioni Cingulate (NASDAQ:CINGW)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Cingulate (NASDAQ:CINGW)
Storico
Da Set 2023 a Set 2024